Identification of zebrafish A2 adenosine receptors and expression in developing embryos

Gene Expression Patterns

Volumn 9, Issue 3, 2009, Pages 144-151

  Boehmler, Wendy ^a   Petko, Jessica ^a   Woll, Matthew ^a   Frey, Colleen ^a   Thisse, Bernard ^b   Thisse, Christine ^b   Canfield, Victor A ^a   Levenson, Robert ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

A2 adenosine receptors; Caffeine; Central nervous system; MPTP; Parkinson's disease; Zebrafish

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE A2 RECEPTOR; CAFFEINE; POLYPEPTIDE;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CHROMOSOME 21; CHROMOSOME 5; CHROMOSOME 8; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; DRUG RESEARCH; EMBRYO; EMBRYO DEVELOPMENT; EXPRESSED SEQUENCE TAG; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; GENETIC DATABASE; IN SITU HYBRIDIZATION; MAMMAL; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SYMPTOM; ZEBRA FISH;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BASE SEQUENCE; CAFFEINE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMOSOME MAPPING; DNA; GENE EXPRESSION PROFILING; HUMANS; LARVA; MOLECULAR SEQUENCE DATA; NEUROTOXINS; PARKINSON DISEASE; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTORS, ADENOSINE A2; SEQUENCE HOMOLOGY, NUCLEIC ACID; SOMITES; ZEBRAFISH; ZEBRAFISH PROTEINS;

ANIMALIA; DANIO RERIO; MAMMALIA;

EID: 58549090296     PISSN: 1567133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gep.2008.11.006     Document Type: Article

References (29)

1. Anichtchik O.V., Kaslin J., Peitsaro N., Scheinin M., and Panula P. (Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J. Neurochem. 88 (2004) 443-453
2. Betarbet R., Sherer T.B., and Greenamyre J.T. Animal models of Parkinson's disease. Bioessays 24 (2002) 308-318
3. Bhidayasiri R., and Truong D.D. Motor complications in Parkinson disease: clinical manifestations and management. J. Neurol. Sci. 266 (2008) 204-215
4. Bretaud S., Lee S., and Guo S. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol. Teratol. 26 (2004) 857-864
5. Chen J.F., Xu K., Petzer J.P., Staal R., Xu Y.H., Beilstein M., Sonsalla P.K., Castagnoli K., Castagnoli Jr. N., and Schwarzschild M.A. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J. Neurosci. 21 (2001) RC143
6. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38 (2001) 107-125
7. Devereux J., Haeberli P., and Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12 (1984) 387-395
8. Felsenstein J. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17 (1981) 368-376
9. Fitch W.M., and Margoliash E. Construction of phylogenetic trees. Science 155 (1967) 279-284
10. Fredholm B.B., Chen J.F., Masino S.A., and Vaugeois J.M. Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 385-412
11. Fredholm B.B., Irenius E., Kull B., and Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 61 (2001) 443-448
12. Holzschuh J., Ryu S., Aberger F., and Driever W. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech. Dev. 101 (2001) 237-243
13. Jacobson K.A., and Gao Z.G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5 (2006) 247-264
14. Jarvis M.F., and Williams M. Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680. Eur. J. Pharmacol. 168 (1989) 243-246
15. Kalda A., Yu L., Oztas E., and Chen J.F. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease. J. Neurol. Sci. 248 (2006) 9-15
16. Kull B., Svenningsson P., and Fredholm B.B. Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol. Pharmacol. 58 (2000) 771-777
17. Kwok C., Korn R.M., Davis M.E., Burt D.W., Critcher R., McCarthy L., Paw B.H., Zon L.I., Goodfellow P.N., and Schmitt K. Characterization of whole genome radiation hybrid mapping resources for non-mammalian vertebrates. Nucleic Acids Res. 26 (1998) 3562-3566
18. Lam C.S., Korzh V., and Strahle U. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur. J. Neurosci. 21 (2005) 1758-1762
19. Langston J.W., and Ballard Jr. P.A. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine. N. Engl. J. Med. 309 (1983) 310
20. Ma P.M. Catecholaminergic systems in the zebrafish. IV. Organization and projection pattern of dopaminergic neurons in the diencephalon. J. Comp. Neurol. 460 (2003) 13-37
21. McKinley E.T., Baranowski T.C., Blavo D.O., Cato C., Doan T.N., and Rubinstein A.L. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res. Mol. Brain Res. 141 (2005) 128-137
22. Ning Z., Cox A.J., and Mullikin J.C. SSAHA: a fast search method for large DNA databases. Genome Res. 11 (2001) 1725-1729
23. Okusa M.D. A(2A) adenosine receptor: a novel therapeutic target in renal disease. Am. J. Physiol. Renal. Physiol. 282 (2002) F10-F18
24. Pinna A., Wardas J., Simola N., and Morelli M. New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists. Life Sci. 77 (2005) 3259-3267
25. Schapira A.H., Bezard E., Brotchie J., Calon F., Collingridge G.L., Ferger B., Hengerer B., Hirsch E., Jenner P., Le Novere N., Obeso J.A., Schwarzschild M.A., Spampinato U., and Davidai G. Novel pharmacological targets for the treatment of Parkinson's disease. Nat. Rev. Drug Discov. 5 (2006) 845-854
26. Schwarzschild M.A., Agnati L., Fuxe K., Chen J.F., and Morelli M. Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci. 29 (2006) 647-654
27. Schwarzschild M.A., Xu K., Oztas E., Petzer J.P., Castagnoli K., Castagnoli Jr. N., and Chen J.F. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease. Neurology 61 (2003) S55-S61
28. Svenningsson P., Le Moine C., Kull B., Sunahara R., Bloch B., and Fredholm B.B. Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80 (1997) 1171-1185
29. Thisse C., and Thisse B. High resolution in situ hybridization to whole-mount zebrafish embryos. Nature Protocols 3 (2008) 59-69